Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio C Wolff

Showing results (1-10 of 320) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2020
CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard?Antonio C Wolff
The New England Journal of Medicine|December 14, 2016
CDK4 and CDK6 Inhibition in Breast Cancer - A New StandardAntonio C Wolff
International Journal of Fertility and Women'S Medicine|February 14, 2006
Current status of taxanes as adjuvant therapy for early-stage breast cancerAntonio C Wolff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2023
Flashback Foreword: Multigene Predictor for Chemotherapy Response in Breast CancerAntonio C Wolff
Current Opinion in Oncology|November 1, 2002
Systemic therapyAntonio C Wolff
The Oncologist|September 19, 2003
Liposomal anthracyclines and new treatment approaches for breast cancerAntonio C Wolff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Estrogen receptor: a never ending story?Antonio C Wolff, Mitch Dowsett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Evolving Role of the Estrogen Receptor as a Predictive Biomarker: ESR1 Mutational Status and Endocrine Resistance in Breast CancerJosh Lauring, Antonio C Wolff
Oncology (Williston Park, N.Y.)|June 24, 2009
Pregnancy and fertility with breast cancer: what are the options?Roisin Connolly, Antonio C Wolff
Expert Review of Anticancer Therapy|September 26, 2007
Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancerSusanne Briest, Antonio C Wolff
Pageof 32

Showing results (1-10 of 320) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2020
CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard?Antonio C Wolff
The New England Journal of Medicine|December 14, 2016
CDK4 and CDK6 Inhibition in Breast Cancer - A New StandardAntonio C Wolff
International Journal of Fertility and Women'S Medicine|February 14, 2006
Current status of taxanes as adjuvant therapy for early-stage breast cancerAntonio C Wolff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2023
Flashback Foreword: Multigene Predictor for Chemotherapy Response in Breast CancerAntonio C Wolff
Current Opinion in Oncology|November 1, 2002
Systemic therapyAntonio C Wolff
The Oncologist|September 19, 2003
Liposomal anthracyclines and new treatment approaches for breast cancerAntonio C Wolff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Estrogen receptor: a never ending story?Antonio C Wolff, Mitch Dowsett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Evolving Role of the Estrogen Receptor as a Predictive Biomarker: ESR1 Mutational Status and Endocrine Resistance in Breast CancerJosh Lauring, Antonio C Wolff
Oncology (Williston Park, N.Y.)|June 24, 2009
Pregnancy and fertility with breast cancer: what are the options?Roisin Connolly, Antonio C Wolff
Expert Review of Anticancer Therapy|September 26, 2007
Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancerSusanne Briest, Antonio C Wolff
Pageof 32